← Back to Search

Embolization Agent

Gel-Bead Embolization for Knee Osteoarthritis (GAE Trial)

N/A
Waitlist Available
Led By Anish Ghodadra, MD
Research Sponsored by Anish Ghodadra
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients between ages 18 and 75 with moderate/severe knee pain secondary to primary osteoarthritis. Moderate/severe pain will be defined as pain 30 mm to 100 mm on the Visual Analog Pain Scale (where 0 denotes 'no pain' and 100 mm denotes worst pain imaginable')
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 6 months from treatment
Awards & highlights

GAE Trial Summary

This trial will test whether or not transcatheter arterial embolization can help relieve pain and improve functionality in patients with mild to moderate knee osteoarthritis.

Who is the study for?
This trial is for adults aged 18-75 with moderate to severe knee pain due to osteoarthritis, who haven't improved after 3 months of treatments like painkillers or steroids. They should have a certain level of arthritis on x-rays but can't join if they've had a knee replacement, have kidney issues, recent injuries, infections, blood clotting problems, severe artery disease, cancer, are pregnant or deemed fit for knee surgery.Check my eligibility
What is being tested?
The study tests Gel-Bead embolization in patients with mild to moderate knee osteoarthritis. It aims to see if blocking arteries in the knee using these beads reduces pain and improves function while cutting down opioid use.See study design
What are the potential side effects?
While not explicitly stated here, similar procedures may cause soreness at the injection site, allergic reactions to materials used during embolization (like contrast dye), temporary numbness or tingling in the leg and potential risks associated with angiography.

GAE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

GAE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 6 months from treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 6 months from treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Overall efficacy of treatment
Secondary outcome measures
30-second chair stand test
6-minute walk test
Change in KOOS Quality of Life Scale
+1 more

GAE Trial Design

1Treatment groups
Experimental Treatment
Group I: Gel-Bead EmbolizationExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Gel-Bead embolization
2021
N/A
~20

Find a Location

Who is running the clinical trial?

Anish GhodadraLead Sponsor
Anish Ghodadra, MDPrincipal InvestigatorUniversity of Pittsburgh

Media Library

Gel-Bead Embolization Particles (Embolization Agent) Clinical Trial Eligibility Overview. Trial Name: NCT04951479 — N/A
Osteoarthritis Research Study Groups: Gel-Bead Embolization
Osteoarthritis Clinical Trial 2023: Gel-Bead Embolization Particles Highlights & Side Effects. Trial Name: NCT04951479 — N/A
Gel-Bead Embolization Particles (Embolization Agent) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04951479 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings left for potential participants in this investigation?

"As per clinicaltrials.gov, this research endeavour is presently searching for participants. The trial began recruiting on the 3rd of November 2021 and its details were last altered on the 7th of November 2022."

Answered by AI

Are adolescents being included in the experimental protocol for this trial?

"To be eligible for this clinical trial, applicants must be between 18 and 75 years old. Additionally, there are 38 trials available to minors and 657 specifically designed for seniors over 65."

Answered by AI

How many participants are enrolled in this research endeavor?

"Affirmative. Clinicaltrials.gov records confirm that this clinical trial, which was initially advertised on November 3rd 2021, is actively searching for participants. 15 patients are needed to be enlisted at one site."

Answered by AI

Am I an eligible candidate for this research endeavor?

"For admittance to this medical experiment, participants must suffer from arthrosis and be between 18-75 years of age. Approximately 15 individuals will be accepted into the study."

Answered by AI

Who else is applying?

What state do they live in?
Pennsylvania
Florida
What site did they apply to?
UPMC Shadyside
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Geniculate Artery Embolization for Knee Osteoarthritis
Anish Ghodadra 2021. "Geniculate Artery Embolization for Knee Osteoarthritis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04951479.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top